Mathieu Mateo

Title: The Innovative Contributions of Mathieu Mateo

Introduction

Mathieu Mateo is a notable inventor based in Lyons, France. He has made significant strides in the field of vaccine development, particularly focusing on the Lassa virus. His work has the potential to impact public health positively.

Latest Patents

Mathieu Mateo holds a patent for a Lassa vaccine. This invention relates to a recombinant measles virus that expresses Lassa virus polypeptides. It specifically concerns immunogenic Lassa virus particles expressed by a measles virus and/or virus-like particles (VLPs) that contain proteins of the Lassa virus. These recombinant infectious particles are capable of replicating in a host after administration. The invention provides various means, including nucleic acid constructs, vectors, cells, and rescue systems, to produce these recombinant infectious particles. Furthermore, it relates to the use of these particles in a composition, particularly in a vaccine formulation, for the treatment or prevention of Lassa virus infections.

Career Highlights

Throughout his career, Mathieu Mateo has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His contributions to vaccine research and development have been recognized within the scientific community.

Collaborations

Mathieu has collaborated with notable colleagues, including Sylvain Baize and Frédéric Tangy. These partnerships have furthered his research and innovation in the field of virology.

Conclusion

Mathieu Mateo's work in developing a Lassa vaccine showcases his commitment to advancing medical science. His innovative approach to vaccine formulation has the potential to save lives and improve health outcomes.